Tap into our Expert Clinical Network Prime received a request for a nonformulary biologic in a young patient with severe Crohn’s disease, as the provider documented past failures of a biologic on...

Footnotes When we say we are different from our competition, we truly mean it. At Prime, we are driven by our purpose of providing the care we would want for our loved ones. Explore how we stay...

Year 2 Prime Therapeutics’ leading research shows 1 in 12 remain on a GLP-1 drug for obesity at three years. Findings also show improved persistence with high-potency, obesity-approved GLP-1...

Ashley Block Week of Service is an annual event that allows our employees to come together to support our five charity partners, many of which address the major health care conditions we help our...

In this episode of "Beyond the Script," join Jami Snyder, Ann Walker and Tina Hawkins, PharmD to learn more about the need for states to closely manage physician administered drugs (PADs) and how...

Whitepaper Tab 1 Myth 1 Myth 2 Myth 3 Myth 4 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed nec ornare mi. Praesent ultrices ipsum eget est rutrum, eget congue orci molestie. Sed diam...

As prescription opioid overdoses rise in the U.S., the Prime/MRx Special Investigations Unit (SIU) shares how to identify if someone has overdosed and how you can help save a life

Zabrina Watkins Our passion Our people “At Prime we’re committed to creating an open, inclusive culture that’s purpose-oriented and focused on providing meaningful work for our employees. To do...

Senior Account Manager - Remote Investment Accountant, Principal - Remote Job description: The Senior Financial Application Analyst is responsible for the administration of the Hyperion application...

Jessica Johnson, clinical consultant, shares how to identify and prevent opioid overdoses

New clinical publication from Prime Therapeutics explores the latest insights for GLP-1s, including trends in spend, drugs in the pipeline, management strategies and more

April 14, 2025 Author: Simone Ndujiuba, PharmD, BCOP In the United States, pancreatic cancer is the fourth leading cause of cancer related death.¹ In 2023, approximately 64,050 people were...

From cutting-edge system solutions to powerful stakeholder partnerships, the Medicaid Enterprise Systems Conference delivered key insights and connections that will shape health care modernization...

Clinical Solutions Vice President (Remote) Job description: The Medicare Part D pharmacy programs manager manages the coordination of benefits in the pharmacy program with Medicare Part D plans,...

Real-world, integrated data follows-up on previous insights, analytics.

High Cost Therapy Profile Eyebrow High-Cost Therapy Profile: February Detailed information about Marnetegragene autotemcel Intravenous (IV) Gene Therapy/Immunology Marnetegragene autotemcel...

NCCN Recommendations for use of immunoglobulin² Intervention CAR T BsAbs Other indications Immunoglobulin replacement After CAR T-cell therapy, regular immune globulin infusions based on clinical...

FDA approved BiTEs: Brand name Generic name Route Target Indication First FDA indication approval date Blincyto Blinatumomab IV anti-CD19 / anti-CD3 Acute lymphocytic leukemia 12/3/2014 Columvi...

Edwards joins as president, markets.

Designation demonstrates highest level of commitment to quality health care